• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

DXBLU:LX

453.7100 USD 0.00000.00%

As of 08:04:07 ET on 10/23/2014.

Snapshot for Candriam Equities L Biotechnology (DXBLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 335.1400 - 459.5300 Beta vs BTK: 0.8406

ETF Chart for DXBLU

No chart data available.
  • DXBLU:LX 453.7100
  • 1D
  • 1M
  • 1Y
453.7100
Interactive DXBLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DXBLU

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for DXBLU

NAV -
Assets (M) (on 2014-10-22) 585.5324
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for DXBLU

No dividends reported

Performance for DXBLU

1-Month +1.38% 1-Year +27.65%
3-Month +10.52% 3-Year +40.23%
Year To Date +20.91% 5-Year +27.93%
Expense Ratio -

Top Fund Holdings for DXBLU

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 524,000 56,371,920 9.162%
Celgene Corp 539,000 51,215,780 8.324%
Amgen Inc 348,000 48,504,240 7.883%
Biogen Idec Inc 114,000 39,106,560 6.356%
Alexion Pharmaceuticals Inc 174,500 29,541,105 4.801%
Regeneron Pharmaceuticals Inc 78,000 27,340,560 4.444%
Illumina Inc 105,000 18,832,800 3.061%
Vertex Pharmaceuticals Inc 200,000 18,714,000 3.042%
BioMarin Pharmaceutical Inc 198,000 14,101,560 2.292%
Salix Pharmaceuticals Ltd 76,000 12,092,360 1.965%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil